Literature DB >> 1655133

Use of thalidomide in leprosy.

M F Waters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655133      PMCID: PMC1670598          DOI: 10.1136/bmj.303.6800.470-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  NECROTIZING REACTIONS IN LEPROMATOUS LEPROSY. A CLINICAL AND HISTOLOGIC STUDY.

Authors:  M F WATERS; D S RIDLEY
Journal:  Int J Lepr       Date:  1963 Oct-Dec

2.  Use of thalidomide in leprosy.

Authors:  C L Crawford
Journal:  BMJ       Date:  1991-06-29

3.  Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

Authors:  P M Fullerton; D J O'Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

4.  Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males.

Authors:  S M Gad; E J Shannon; W A Krotoski; R C Hastings
Journal:  Lepr Rev       Date:  1985-03       Impact factor: 0.537

5.  Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo.

Authors:  U Runne; C E Orfanos
Journal:  Arch Dermatol       Date:  1977-06

6.  Development of polyneuropathy during thalidomide therapy.

Authors:  C H Wulff; H Høyer; G Asboe-Hansen; H Brodthagen
Journal:  Br J Dermatol       Date:  1985-04       Impact factor: 9.302

7.  Acute necrotizing lepromatous lymphadenitis: an erythema-nodosum-leprosum-like reaction in lymph nodes.

Authors:  A B Karat; S Karat; C K Job; D Sudarsanam
Journal:  Br Med J       Date:  1968-10-26

8.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

Authors:  E P Sampaio; E N Sarno; R Galilly; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

  8 in total
  2 in total

1.  Use of thalidomide in leprosy.

Authors:  M Hooper
Journal:  BMJ       Date:  1991-11-30

2.  Use of thalidomide in leprosy.

Authors:  C L Crawford
Journal:  BMJ       Date:  1991-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.